Jeffrey Cornell, Portfolio Manager at Johnson Investment Counsel, says CVS Health Corp (NYSE:CVS) continues to grow sales by making acquisitions.
They bought the Target (NYSE:TGT) pharmacy business. They’ve made some other big acquisitions here, which has been very helpful. Their old Caremark business that they bought years ago, which is basically mail-order pharmacy, continues to win over a lot of contracts, and we expect continued consolidation within that industry.
So it’s very positive for them, and the other leader in that field also, which is Walgreens (NASDAQ:WBA). CVS has a yield that is little bit under the market. It’s about 1.7%. They’ve got plenty of free cash flow. They’ve got about $4 billion in free cash flow that they can do what they would like to do to increase that yield, do additional buybacks or whatever.
CVS Health Corp (CVS) Cash Flow Fuels 30% Dividend Growth Rate
February 09, 2016
CVS Caremark Corporation (CVS) and Walgreen Co. (WAG) to Benefit from Obamacare and Generic Drugs
December 10, 2013
Medical Research Service and Biotech Continues to Grow in China
August 24, 2012
Amazon.com, Inc. (NASDAQ:AMZN) Continues Disrupting Retail; Amazon Prime Continues Attracting Shoppers
July 12, 2016